cached image

David M. Holtzman

Affiliations: 
Neurology Washington University, Saint Louis, St. Louis, MO 
Area:
Alzheimer's, amyloid
Website:
http://neuro.wustl.edu/aboutus/facultybiographies/holtzman.htm
Google:
"David Holtzman"
Bio:

David Holtzman is the Andrew B. and Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer's Disease Research Center, and a member of the Hope Center for Neurological Disorders. A major interest in his lab is in understanding basic mechanisms underlying acute and chronic cell dysfunction in the CNS particularly as these mechanisms may relate to Alzheimer's disease (AD) and injury to the developing brain.

Mean distance: 14.48 (cluster 31)
 
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schindler SE, Li Y, Todd KW, et al. (2019) Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Patel TK, Habimana-Griffin L, Gao X, et al. (2019) Dural lymphatics regulate clearance of extracellular tau from the CNS. Molecular Neurodegeneration. 14: 11
Gordon BA, Blazey TM, Christensen J, et al. (2019) Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain : a Journal of Neurology
Toedebusch CD, McLeland JS, Schaibley CM, et al. (2019) Multi-Modal Home Sleep Monitoring in Older Adults. Journal of Visualized Experiments : Jove
Ju YS, Holtzman DM. (2019) Reply to "Obstructive sleep apnea treatment and amyloid-β in cerebrospinal fluid". Annals of Neurology
Holth JK, Fritschi SK, Wang C, et al. (2019) The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science (New York, N.Y.)
Lucey BP, McCullough A, Landsness EC, et al. (2019) Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease. Science Translational Medicine. 11
Morris JC, Schindler SE, McCue LM, et al. (2019) Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. Jama Neurology
Ju YS, Zangrilli MA, Finn MB, et al. (2018) Obstructive sleep apnea treatment, slow wave activity, and amyloid-β. Annals of Neurology
Babulal GM, Chen S, Williams MM, et al. (2018) Depression and Alzheimer's Disease Biomarkers Predict Driving Decline. Journal of Alzheimer's Disease : Jad
See more...